55 studies found for:    Open Studies | "Spondylitis, Ankylosing"
Show Display Options
Rank Status Study
1 Recruiting A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
2 Not yet recruiting An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Condition: Spondylitis, Ankylosing
Interventions: Drug: Infliximab;   Drug: NSAIDs;   Drug: DMARDs
3 Recruiting Progression of Spinal Fusion in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention:
4 Recruiting 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
Condition: Spondylitis, Ankylosing
Interventions: Drug: Secukinumab;   Drug: Placebo secukinumab
5 Not yet recruiting 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: Secukinumab;   Biological: Placebo
6 Recruiting Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial
Condition: Spondylitis, Ankylosing
Intervention: Behavioral: Brief Intervention
7 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
8 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
9 Recruiting Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
Condition: Ankylosing Spondylitis
Intervention:
10 Unknown  Prednisolone in Active Ankylosing Spondylitis (AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: prednisolone
11 Not yet recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
12 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
13 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
14 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
15 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
16 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
17 Recruiting A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
18 Recruiting Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
Condition: Ankylosing Spondylitis
Intervention:
19 Unknown  Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
Conditions: Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Ankylosing Spondylitis
Intervention:
20 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years